AstraZeneca (AZN) News Today $74.36 +0.83 (+1.13%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Meitav Investment House Ltd. Buys 205,000 Shares of AstraZeneca PLC (NASDAQ:AZN)Meitav Investment House Ltd. boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 616.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 238,270 shares of the compaFebruary 21 at 6:09 AM | marketbeat.comLost Money on AstraZeneca PLC(AZN)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyFebruary 21 at 5:45 AM | prnewswire.comBryn Mawr Capital Management LLC Has $1.03 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)Bryn Mawr Capital Management LLC trimmed its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 72.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,741 shares of the company's stock afFebruary 21 at 4:36 AM | marketbeat.comAtria Wealth Solutions Inc. Acquires 6,970 Shares of AstraZeneca PLC (NASDAQ:AZN)Atria Wealth Solutions Inc. raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 16.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,035 shares of the company's stock after purchasing an addFebruary 21 at 4:10 AM | marketbeat.comAZN Deadline: AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law FirmFebruary 21 at 12:35 AM | prnewswire.comAstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge FundsFebruary 20 at 5:49 PM | insidermonkey.comFinal Deadline for the AstraZeneca PLC Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - AZNFebruary 20 at 3:56 PM | prnewswire.comAstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4B as Firm Expands Cancer PipelineFebruary 20 at 3:00 PM | investopedia.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca PLC Lawsuit – AZNFebruary 20 at 1:25 PM | globenewswire.comFaruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZNFebruary 20 at 10:24 AM | prnewswire.comFibroGen sells China unit to AstraZeneca in deal worth $160 millionFebruary 20 at 6:40 AM | reuters.comAstraZeneca PLC Class Action: The Gross Law Firm Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZNFebruary 20 at 5:45 AM | prnewswire.comTruist Financial Corp Has $15.98 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Truist Financial Corp trimmed its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 243,923 shares of the company's stock after selling 12,517 shares duFebruary 20 at 4:11 AM | marketbeat.comCatalyst Capital Advisors LLC Has $29,000 Holdings in AstraZeneca PLC (NASDAQ:AZN)Catalyst Capital Advisors LLC decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 98.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 449 shares of the company's stock after selling 35,750 sharesFebruary 20 at 4:02 AM | marketbeat.comAZN Deadline: Rosen Law Firm Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZNFebruary 19 at 5:05 PM | businesswire.comDeadline Soon: AstraZeneca PLC (AZN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitFebruary 19 at 2:36 PM | tmcnet.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZenecaFebruary 19 at 11:23 AM | globenewswire.comWhat's a Good Price for AstraZeneca Stock?February 19 at 11:12 AM | fool.comAstraZeneca PLC (NASDAQ:AZN) Holdings Raised by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 153.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 153,695 shaFebruary 19 at 3:37 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZNFebruary 18 at 6:21 PM | prnewswire.comAstraZeneca PLC Class Action: Levi & Korsinsky Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 – AZNFebruary 18 at 2:21 PM | globenewswire.comAZN DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZNFebruary 18 at 12:30 PM | globenewswire.comAstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitFebruary 18 at 12:00 PM | prnewswire.comAZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law FirmFebruary 18 at 9:37 AM | prnewswire.comAstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereFebruary 18 at 8:54 AM | finance.yahoo.comKornitzer Capital Management Inc. KS Lowers Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Kornitzer Capital Management Inc. KS lowered its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 16.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 299,402 shares of the company's stock after selling 60,910 shares dFebruary 18 at 5:52 AM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZNFebruary 18 at 5:45 AM | prnewswire.comCIBC Asset Management Inc Has $15.37 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)CIBC Asset Management Inc cut its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 234,616 shares of the company's stock after selling 3,652 sharesFebruary 18 at 5:24 AM | marketbeat.comAmericana Partners LLC Acquires 14,309 Shares of AstraZeneca PLC (NASDAQ:AZN)Americana Partners LLC boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 50.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,722 shares of the company's stFebruary 18 at 4:50 AM | marketbeat.comStrategic Financial Concepts LLC Takes $1.68 Million Position in AstraZeneca PLC (NASDAQ:AZN)Strategic Financial Concepts LLC purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 25,632 shares of the company's stock, valued atFebruary 18 at 4:22 AM | marketbeat.comAnalysts Set AstraZeneca PLC (NASDAQ:AZN) PT at $89.75February 18 at 1:29 AM | americanbankingnews.comAZN DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZNFebruary 17, 2025 | investing.comAstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption – Hagens BermanFebruary 17, 2025 | globenewswire.comPittenger & Anderson Inc. Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)Pittenger & Anderson Inc. grew its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,741 shares of the company's stock after buying an additiFebruary 17, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by James Investment Research Inc.James Investment Research Inc. lowered its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 20.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 66,235 shares of the company's stock after selling 16,853February 17, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by NTV Asset Management LLCNTV Asset Management LLC reduced its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 16.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,430 shares of the cFebruary 17, 2025 | marketbeat.comAlphaCentric Advisors LLC Purchases Shares of 31,685 AstraZeneca PLC (NASDAQ:AZN)AlphaCentric Advisors LLC purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 31,685 shares of the company's stock, valued at approximaFebruary 17, 2025 | marketbeat.comAZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC ...February 16, 2025 | gurufocus.comAZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 16, 2025 | globenewswire.comAZN DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by thFebruary 16, 2025 | investing.comAstraZeneca PLC (NASDAQ:AZN) Sees Significant Increase in Short InterestAstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the target of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 16,940,000 shares, an increase of 12.2% from the January 15th total of 15,100,000 shares. Based on an average daily trading volume, of 6,050,000 shares, the short-interest ratio is currently 2.8 days.February 16, 2025 | marketbeat.comWealthPlan Investment Management LLC Has $5.79 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)WealthPlan Investment Management LLC raised its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 88,424 shares of the company's stockFebruary 16, 2025 | marketbeat.comAZN IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZNFebruary 15, 2025 | globenewswire.comAZN Deadline: AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit ...February 15, 2025 | gurufocus.comAZN Deadline: AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit Filed by The Rosen Law FirmFebruary 15, 2025 | prnewswire.com2 Healthcare Stocks That Tumbled in 2024February 15, 2025 | fool.comAstraZeneca PLC (NASDAQ:AZN) Stock Position Raised by Pictet North America Advisors SAPictet North America Advisors SA raised its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 214.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,562 shares of the company's sFebruary 15, 2025 | marketbeat.comAstraZeneca (NASDAQ:AZN) Stock Rating Upgraded by UBS GroupFebruary 15, 2025 | americanbankingnews.comVan ECK Associates Corp Has $30.11 Million Stake in AstraZeneca PLC (NASDAQ:AZN)Van ECK Associates Corp increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 459,560 shares of the company's stock after purchasinFebruary 15, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Given Average Recommendation of "Buy" by BrokeragesShares of AstraZeneca PLC (NASDAQ:AZN - Get Free Report) have received an average rating of "Buy" from the ten ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, seven have given a buy rating and two haveFebruary 15, 2025 | marketbeat.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.390.60▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼5623▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
